The Active Pharmaceutical Ingredients Directory offers key market opportunities by providing extensive information on over 5,000 API companies and 25,000 executives worldwide. It connects users to ...

DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global active ...

DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...

AbbVie is investing $380 million to build two new active pharmaceutical ingredient (API) manufacturing facilities at its ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

Jan 31 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world's largest generic drugs ...

Less than two months into its "Pivot to Growth" strategy under a new CEO, Israeli-American generics giant Teva Pharmaceutical could be weighing a major shake-up of its key drug ingredients business.

TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...

The market for the supply and manufacture of active pharmaceutical ingredients is constantly changing, with several trends and factors driving these developments. Understanding how to reap the ...